Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC8576 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 12771 |
0.1-0.2 | 16274 |
0.2-0.3 | 1291 |
0.3-0.4 | 405 |
0.4-0.5 | 111 |
0.5-0.6 | 24 |
0.6-0.7 | 9 |
0.7-0.8 | 3 |
0.8-0.85 | 1 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC8576 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 966 |
0.1-0.2 | 6844 |
0.2-0.3 | 982 |
0.3-0.4 | 280 |
0.4-0.5 | 63 |
0.5-0.6 | 15 |
0.6-0.7 | 5 |
0.7-0.8 | 0 |
0.8-0.85 | 1 |
0.85-0.9 | 3 |
0.9-0.95 | 0 |
0.95-1 | 2 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD9012 |
Phase 2 |
1.0 |
High Similarity |
NPD9013 |
Clinical (unspecified phase) |
0.8929 |
High Similarity |
NPD9041 |
Approved |
0.8929 |
High Similarity |
NPD9039 |
Approved |
0.8929 |
High Similarity |
NPD9040 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD8791 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD8560 |
Clinical (unspecified phase) |
0.641 |
Remote Similarity |
NPD390 |
Approved |
0.641 |
Remote Similarity |
NPD718 |
Approved |
0.6364 |
Remote Similarity |
NPD8948 |
Approved |
0.6098 |
Remote Similarity |
NPD9241 |
Approved |
0.5814 |
Remote Similarity |
NPD874 |
Approved |
0.5814
|
Remote Similarity |
NPD872 |
Approved |